SAN ANTONIO, TX, April 5, 2022 (GLOBE NEWSWIRE) — With the recent FDA approval of EVO Visian® ICL (referred to as “EVO”), patients are lining up to receive the new vision technology, now available in the United States States is available as of April 5, 2022. EVO ICL is an implantable lens that is placed just below the surface of the eye and corrects nearsightedness (with or without astigmatism) to provide clear vision for people struggling with the discomfort of Want to get rid of the hassle and running costs of glasses by wearing contact lenses every day.
Parkhurst NuVision pulls out all the stops for its eager patients and has enlisted reality TV star and former Amazing Race competitor Kent Cothran to host two teams that compete on literally separate flights to produce the manufacturer’s EVO ICL lenses to get back to san antonio, texas california.
There are two teams that started the Amazing Race to EVO on April 5th to secure the EVO lenses in Los Angeles and make the 1,300 mile trek back to Texas:
On the gray team – We have Heather Parkhurst, the wife of Dr. Parkhurst, who is dating Liz. Liz is a bride-to-be and wants to get EVO in time for her upcoming wedding. Liz said she’s most looking forward to shedding glasses and contacts so she can go swimming and diving with her new husband on their upcoming honeymoon.
In the blue team, we have dr. Lauren Libfraind, one of the surgeons at Parkhurst NuVision. She works with Kyle. Kyle is preparing to join the police academy, and one of the departments he’s applying for requires 20/20 vision. He hopes EVO will give him the vision he needs in such a physically demanding job.
Who arrives first? Who gets their EVO first in the United States? Join us live on Instagram as the adventure continues throughout the day!
“These patients have waited years for EVO approval and are excited to finally be able to wake up and see with the clear vision they have always wanted. It kind of reminds me of people camping out in front of the Apple Store ahead of a new iPhone release,” said Dr. Gregory Parkhurst of Parkhurst NuVision, lead clinical investigator in the FDA EVO study and one of the first vision correction practices to conduct EVO in the United States. “More than 1 million EVO procedures have been performed worldwide and we are pleased that EVO is receiving the FDA stamp of approval here in the US. We will conduct the first batch of operations in the US within the next 24 hours. There are currently 14 procedures scheduled so we plan to work well into the night to help all those looking to get the first batch of EVO lenses in the nation.”
About Evo: Long-term vision correction with the EVO ICL is a quick and effective procedure that offers many advantages. EVO can correct vision for a wide range of prescriptions and offers excellent night vision with built-in UV protection. The EVO lens can be an ideal option for patients who do not prefer to wear glasses and contact lenses to see and who are not candidates for LASIK eye surgery. EVO is designed to provide permanent vision correction and for added security it is both removable and interchangeable if needed.
ABOUT PARKHURST NUVISION: Parkhurst NuVision is widely recognized as a premier vision correction surgery center and clinical research facility. The group practice was founded by the award-winning ophthalmologist Dr. Gregory Parkhurst, who has been one of the most experienced ICL surgeons in North America for several years and who implanted the first toric ICL for astigmatism in the USA after FDA approval in 2018. Parkhurst NuVision is proud to serve the community of San Antonio, Texas, as well as the many patients who travel from across the country to benefit from our eye surgery expertise. As a leader in personalized vision interventions, we strive to provide the full spectrum of vision correction solutions including EVO ICL, LASIK, SMILE LASIK, PRK, Laser Lens Treatment (RLE) and Laser Cataract Surgery. Whatever your vision or stage of life, the Parkhurst NuVision team is here to help you see.
CONTACT: Name: Angie Kruse Mobile: (336) 508-4447 Email: firstname.lastname@example.org